2.08BMarket Cap-12205P/E (TTM)
15.270High13.630Low1.43MVolume15.180Open15.000Pre Close20.21MTurnover1.80%Turnover RatioLossP/E (Static)152.52MShares16.73552wk High14.71P/B1.09BFloat Cap3.50052wk Low--Dividend TTM79.73MShs Float56.000Historical High--Div YieldTTM10.93%Amplitude1.160Historical Low14.106Avg Price1Lot Size
Wave Life Sciences Stock Forum
Wave Life Sciences Announces First-Ever Therapeutic Rna Editing in Humans Achieved in Restoraation-2 Trial of Wve-006 in Alpha-1 Antitrypsin Deficiency
Wave Life Sciences Ltd: Expects to Share Multidose Data From Restoraation-2 Trial in 2025
In a notable transaction, GSK (LON:GSK) plc, a major player in the pharmaceutical industry, has recently increased its stake in Wave Life Sciences Ltd . (NASDAQ:WVE). The acquisition involved the purchase of 2,791,930 ordinary shares at a price of $8.00 per share, amounting to a total investment of $22.3 million.
This strategic move by GSK plc, which is known for its diverse portfolio of healthca...
No comment yet